Annotation Detail for LILRA1

Basic Information
Top
Gene Symbol: | LILRA1 ( CD85I,LIR-6,LIR6,MGC126563 ) |
---|
Gene Full Name: | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1 |
---|
Band: | 19q13.42 |
---|
Quick Links | Entrez ID:11024; OMIM: 604810; Uniprot ID:LIRA1_HUMAN; ENSEMBL ID: ENSG00000104974; HGNC ID: 6602 |
---|
Relate to Another Database: |
SFARIGene;
denovo-db |
Pathway ID | Pathway Name |
---|
| Signaling in Immune system |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C068073 |
Am 580 |
Am 580 results in increased expression of LILRA1 mRNA | increases expression | 16982809
|
C089730 |
rosiglitazone |
rosiglitazone results in increased expression of LILRA1 mRNA | increases expression | 16982809
|
D015215 |
Zidovudine |
[Zidovudine co-treated with IFNA1 protein] results in increased expression of LILRA1 mRNA | affects cotreatment|increases expression | 20370541
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000163 |
Acquired Immunodeficiency Syndrome |
|
Zidovudine |
5.48 | 9612607 |
MESH:D000544 |
Alzheimer Disease |
|
rosiglitazone |
2.92 | 19621015 |
MESH:D002386 |
Cataract |
|
Am 580 |
4.58 | 17460283 |
MESH:D003092 |
Colitis |
|
Am 580 |
5.61 | 17035595 |
MESH:D003920 |
Diabetes Mellitus |
|
rosiglitazone |
4.72 | 17446233 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
rosiglitazone |
3.01 | 12642470 |
MESH:D004362 |
Drug Toxicity |
|
Zidovudine |
4.33 | 15040536 |
MESH:D004487 |
Edema |
|
rosiglitazone |
4.12 | 12083418 |
MESH:D005234 |
Fatty Liver |
|
rosiglitazone |
10.03 | 19196556 |
MESH:D005234 |
Fatty Liver |
|
Zidovudine |
10.03 | 18299183 |
MESH:D006402 |
Hematologic Diseases |
|
Zidovudine |
5.24 | 12579204 |
MESH:D015658 |
HIV Infections |
|
Zidovudine |
3.69 | 11141242 11698656 11363243 20032539 17358032 |
MESH:D006930 |
Hyperalgesia |
|
rosiglitazone |
4.28 | 12083418 |
MESH:D007249 |
Inflammation |
|
rosiglitazone |
3.32 | 12083418 |
MESH:D007333 |
Insulin Resistance |
|
rosiglitazone |
4.07 | 16306350 |
MESH:D007680 |
Kidney Neoplasms |
|
Zidovudine |
4.17 | 12579204 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Zidovudine |
4.90 | 20370541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
rosiglitazone |
2.52 | 15980055 17347453 |
MESH:D008175 |
Lung Neoplasms |
|
Zidovudine |
2.49 | 18800350 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
rosiglitazone |
3.65 | 16827153 |
MESH:D024821 |
Metabolic Syndrome X |
|
rosiglitazone |
4.77 | 17261469 |
MESH:D048629 |
Micronuclei, Chromosome-Defective |
|
Zidovudine |
6.71 | 17358032 |
MESH:D013274 |
Stomach Neoplasms |
|
Zidovudine |
2.48 | 17696246 |
MESH:D014625 |
Vaginal Neoplasms |
|
Zidovudine |
5.41 | 12579204 |
PharmGKB Accession:PA30376
Releated disease ID |
Related disease Name |
PA446155 | Precursor Cell Lymphoblastic Leukemia-Lymphoma |